Agora Labs Raises €4.3M to Double Hospital Network to 100

Italian health-tech company Agora Labs has raised €4.3 million to double its hospital network to 100 facilities across Europe, the US, the Middle East and India.

P101 SGR led the round, according to FinSMEs. The Mussetto family — owners of the holding company Infinite Five, which specialises in martech, data analysis and robotics — participated. Infinite Five backs startups and scaleups with capital and industrial expertise, though the company did not disclose the size of its individual stake.

What will the money fund?

Two priorities: international expansion and hiring. Agora Labs plans to grow from its current 50 healthcare facilities to 100 hospitals in the European and US markets, and push into the Middle East and India. Roughly 20 technical and commercial professionals will join in the coming months — a headcount increase that, for a company of this size, is substantial.

Doubling the network matters because the product itself depends on scale: the more hospitals connected, the larger the patient populations available for multicentre medical research.

Who built the company?

Agora Labs was founded in Rome by Davide Zaccagnini and Fabio Giulietto. Zaccagnini is a vascular surgeon and biomedical informatician trained at MIT. Giulietto is an engineer with an MBA from Imperial College London. The company is headquartered in Rome and Collevecchio, Italy.

The startup is a deep tech company. Its infrastructure makes hospitals' clinical data usable for medical and scientific research while fully safeguarding patient privacy — at least according to the company's own description of its technology.

How does the technology actually work?

The architecture has three layers, and each is worth stress-testing.

• On-premise computing. Agora Labs installs a dedicated computing node, powered by NVIDIA GPUs, at each facility in the network. NVIDIA is the company's technology partner. The hospital retains full control of its data within its own infrastructure.
• Anonymisation. Data is structured and standardised by specialised LLMs and anonymised through what the company calls irreversible mathematical anonymisation processes, designed to protect data even against quantum computing capabilities. The claim of quantum resistance is the company's own; it has not been independently verified.
• Federated learning. Data from different hospitals' nodes is curated and standardised using federated AI algorithms. Medical research centres and pharmaceutical companies can run multicentre studies on large international populations across the geographies the network covers. AI models are trained and validated locally, with only the outputs and inferences shared.

The upshot: hospitals can monetise their data assets, and life sciences players can accelerate research into new diagnostic and therapeutic solutions.

Where did the company come from?

Agora Labs grew out of a European research project on technologies for the secure sharing of clinical data, launched after the EU General Data Protection Regulation took effect in 2018. That regulatory origin is more than trivia: GDPR's strict rules on health data are precisely the barrier the company's privacy-first architecture is built to clear.

The company currently operates through an international network of 50 healthcare facilities, ranging from Harvard Medical School to San Raffaele Hospital in Milan.

What is the open question?

The €4.3 million round is modest by deep tech standards, and the company did not disclose its valuation or revenue figures. Doubling a hospital network from 50 to 100 across four regions — including markets with very different regulatory regimes — will test whether the federated model scales as cleanly as the technology pitch suggests.